MedWellAI (MWAI) Research & Development (2015 - 2025)

MedWellAI (MWAI) posted quarterly Research & Development of $250.0 for Q4 2025, down 98.64% quarter-over-quarter from $18324.0 in Q3 2025.

MedWellAI (MWAI) Research & Development (2015 - 2025) Analysis & Trends

MedWellAI (MWAI) has reported Research & Development for 4 consecutive years, with $250.0 the latest figure, recorded in Q4 2025.

In Q4 2025, Research & Development changed N/A year-over-year to $250.0; the TTM figure through Dec 2025 stood at $18574.0 (down 11.12% YoY), while the FY2025 annual figure was $65030.0, changed N/A from the prior year.
Research & Development declined to $250.0 in Q4 2025 per MWAI's latest filing, from $18324.0 in the prior quarter.
Across five years, Research & Development topped out at $18324.0 in Q3 2025 and bottomed at $250.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	R&D (Qtr)
1	Morgan Stanley	338.83 Bn	205.30 Bn	-	1.20 Bn
2	Goldman Sachs	316.34 Bn	-660.01 Bn	-	635.00 Mn
3	Schwab Charles	220.55 Bn	135.80 Bn	-	-
4	Futu Holdings	121.48 Bn	105.59 Bn	733.58 Mn	-65.09 Mn
5	Robinhood Markets	84.07 Bn	66.74 Bn	1.20 Bn	256.00 Mn
6	Iren	68.17 Bn	65.95 Bn	104.86 Mn	-
7	ATIF Holdings	45.42 Bn	45.42 Bn	-	-
8	Interactive Brokers	39.54 Bn	-3.28 Bn	-	-
9	LPL Financial Holdings	28.27 Bn	25.57 Bn	-	26.20 Mn
10	MedWellAI	10.41 Mn	10.42 Mn	-	-

Download Data